Telemedi is a technology company.
Telemedi has raised $7.0M across 1 funding round.
Telemedi has raised $7.0M in total across 1 funding round.
Telemedi is a Poland-based technology company founded in 2014 that builds a plug-and-play digital healthcare platform offering telemedicine, automated triage, AI-driven tools, medical device monitoring, and API integrations.[1][2][5] It primarily serves B2B clients across industries like health insurance (e.g., AXA, Allianz, Generali, PZU), assistance and travel (e.g., Mondial, Europ Assistance), hospitals, banking, telecom, finance, pharmaceuticals (e.g., Novartis), and online businesses, solving the problem of accessible hybrid healthcare by enabling remote consultations via chat, video, apps, infolines, or kiosks, tailored to local markets.[1][2][3][6] The company has shown strong growth momentum, scaling from 1,000 consultations per month in 2017 to 50,000 by 2020, securing 15 international B2B clients by 2019, raising $6.86M in funding, reaching ~550 employees, and generating ~$134M in revenue before being acquired in a corporate majority deal by Mavie, marking a successful exit for investors like Black Pearls VC.[1][2][3]
Telemedi was founded in 2013 (operations starting 2014) in Warsaw, Poland, by Paweł Sieczkiewicz, a former kickboxing champion and serial entrepreneur who serves as CEO.[1][2][4] The idea emerged from recognizing the need for scalable telemedicine solutions amid rising demand for remote health services, leading to early validation through Telefonica's Accelerate program in Prague in 2014.[2] Pivotal moments include rapid traction with 1,000 monthly consultations by 2017, expansion to 15 international B2B clients by 2019, a Madrid office opening in 2021, and explosive growth to 50,000 consultations monthly in 2020 amid the pandemic, fueled by investors like Black Pearls VC (pre-seed lead), PKO VC, Adamed, UNIQA Ventures, and Flashpoint VC.[1][2][4][6]
Telemedi rides the telehealth and digital health wave, accelerated by the COVID-19 pandemic, which boosted remote care adoption in Central/Eastern Europe and beyond, where traditional healthcare faces access gaps in insurance, travel, and finance sectors.[1][2][6] Timing aligns with rising demand for hybrid models—blending digital with in-person care—driven by aging populations, insurer cost pressures, and AI/monitoring tech maturity, positioning it favorably against competitors in a market projected for continued growth.[1][3] It influences the ecosystem by enabling non-health firms (e.g., banks, telcos) to embed healthcare, upskilling partners like SIGNAL IDUNA, and expanding via Mavie acquisition to pioneer regional accessibility, including initiatives like "Doctors for Ukraine" with DocPlanner.[1][6]
Under Mavie ownership and Paweł Sieczkiewicz's leadership, Telemedi is poised for pan-European expansion, enhancing portfolios with AI and monitoring while targeting new markets in Central/Eastern Europe and beyond.[1] Trends like AI triage, embedded insurance health, and global travel recovery will propel growth, potentially evolving its influence from regional leader to key enabler of preventative, borderless care. This builds on its B2B dominance, tying back to its core mission of safer, hybrid health access worldwide.[1][2][6]
Telemedi has raised $7.0M in total across 1 funding round.
Telemedi's investors include TJ Nahigian, Cedar Capital Group, Flashpoint VC, Gradient Ventures, Matrix Capital.
Telemedi has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in January 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2021 | $7.0M Series A | TJ Nahigian, Cedar Capital Group, Flashpoint VC, Gradient Ventures, Matrix Capital |